Search

everythinglearnresearchcommunity

for

Search:↓

The new gel combining minoxidil and tofacitinib effectively treats alopecia areata by promoting hair growth and reducing inflammation.

Booster shots of mRNA vaccines for COVID-19 increased protective antibodies without worsening autoimmune skin conditions in patients.

Lichen planus is a chronic autoimmune disease that is hard to treat and more common in women.

Allergies, especially dust mite allergy, may worsen alopecia areata, and desensitization could help reduce its severity.

Tofacitinib regrew hair in a man with total hair loss but raised cytokine levels, needing more research on possible side effects.

Yikgeebohyul-tang promotes hair growth and could help treat hair loss.

CLEC10A and interleukin-42 can help identify PCOS patients' response to Metformin treatment.

The right cells and signals can potentially lead to scarless wound healing, with a mix of natural and external wound healing controllers possibly being the best way to achieve this.

The conclusion is that Treg-targeted therapies have potential, but more knowledge of Treg biology is needed for effective treatments, including for cancer.

T-cells in alopecia areata scalp show abnormal regulation, leading to less inflammation.

Clausena anisata may be effective in treating acne due to its ability to fight bacteria, reduce inflammation, and possibly lower sebum production.

Children with alopecia areata have immune imbalances and are more likely to have certain health issues.

Alopecia areata is likely an autoimmune disease with unclear triggers, involving various immune cells and molecules, and currently has no cure.

Scalp itching is common and hard to diagnose due to the complex nerve structure of the scalp.

JAK inhibitors and platelet-rich plasma show promise for treating alopecia areata.

Type 2 immunity helps control mite growth in hair follicles, preventing damage.

Multiple pregnancies prevent skin disease but worsen kidney disease in certain mice.

Longdan Xiegan decoction is more effective than conventional medicine for treating eczema.

Certain cytokines may cause or be affected by immune skin diseases, suggesting possible new treatments.

Using fat-derived stem cells with the drug meglumine antimoniate can help control skin disease and reduce parasites in mice with leishmaniasis.

Certain immune-related proteins are higher in people with alopecia and their healthy relatives, hinting at a genetic link.

Personalized medicine in dermatology uses molecular biomarkers to improve diagnosis and treatment but needs further advancements for practical use.

Alopecia areata is an autoimmune condition causing hair loss, linked to genetic factors and immune system issues, with no cure yet.

The immune processes causing VKH and vitiligo are similar in dogs and humans.

Chronic inflammatory skin diseases are caused by disrupted interactions between skin cells and immune cells.

The research confirms that Hidradenitis Suppurativa is characterized by increased inflammation, disrupted skin cell organization, and abnormal metabolic processes.

JAK inhibitors show promise for treating alopecia areata, but more research is needed.

Hair follicle-derived IL-7 and IL-15 are crucial for maintaining skin-resident memory T cells and could be targeted for treating skin diseases and lymphoma.

Understanding and targeting specific molecules can help reduce scarring and promote scar-free healing.

Alopecia areata is an autoimmune disorder causing hair loss, linked to specific hair follicle antigens and genetic factors.